Risk of Malignancy With Systemic Psoriasis Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Risk of Malignancy With Systemic Psoriasis Treatment in the Psoriasis Longitudinal Assessment Registry
J Am Acad Dermatol 2017 Sep 08;[EPub Ahead of Print], D Fiorentino, V Ho, MG Lebwohl, L Leite, L Hopkins, C Galindo, K Goyal, W Langholff, S Fakharzadeh, B Srivastava, RG LangleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.